# ClinicalTrials.gov record NCT05760313

> PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct05760313-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05760313-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05760313-linaclotide-v1.json
- Content SHA-256: `f61c85e7a7438703a21dd8a7da492a2ae129c28fccd1d47a0552a13e01d16905`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05760313 ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

## Sources

<a id="source-ctg-observation-nct05760313-2026-01-06-8b520537947a"></a>
- **ClinicalTrials.gov record NCT05760313 · retained source version 2026-01-06:8b520537947a0ad0aca2539c9ab85590e9975a67e4775c97c170a1d284b8abd1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05760313) (`ctg-observation-nct05760313-2026-01-06-8b520537947a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05760313." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05760313-linaclotide-v1.json SHA-256: f61c85e7a7438703a21dd8a7da492a2ae129c28fccd1d47a0552a13e01d16905.